Table 1.
Tool | Method | Output | Accuracy of predictions, % | References |
---|---|---|---|---|
SwissADME | expert-rules based 2D QSAR |
Drug likeness, pharmacokinetic profile specifying Yes or NO for every investigated biological action | 72-94 | [14] |
admetSAR2.0 | 2D QSAR | Pharmacokinetic profiles, organ (eye, heart, liver) and genomic toxicity specifying the probability of the presence or absence of a biological action. | 72-77 | [18, 19] |
Pred-hERG | 2D QSAR | Ability of a chemical compound to inhibit the human ether-à-go-go related gene (hERG)K+ channels using both a binary and a multiclass model. | 70-89 | [21, 30, 31] |
Pred-Skin | 2D-QSAR | Skin sensitization potential based on multiple QSAR models: prediction by binary model using human data, binary and multiclass predictions of murine skin sensitization potential based on animal data, and binary predictions based on non-animal data, i.e Direct Peptide Reactivity Assay (DPRA), KeratinoSens, and the human Cell Line Activation Test (h-CLAT)] | 70-84 | [20, 21, 31] |
Endocrine Disruptome | Molecular docking | Probability of binding to nuclear receptors. | 70-90 | [22] |
Toxtree | expert-rules based | Carcinogenic and mutagenic potential expressed by Yes or No. | 70 | [23] |
CarcinoPred-EL | 2D QSAR | Carcinogenic potential expressed by Yes or No. | 70 | [24] |